ASTHMA is ch aracte rized by airw ay in flam m atio n, w h ic h can be no w as s es s ed by th e analys is of in duced s p utum . Ten p atie n ts w ith as th m a w er e in ves tigated
Introduction
Infiltratio n of the airw ays mucosa w ith activate d inflammator y ce lls appe ars to be a major fac tor in the pathogene sis of asthma and othe r forms of chronic obstruc tive airw ay disorde rs, such as chronic obstructive pulmonar y dise ase (COPD). The cells and mole cular marke rs of this inflammatio n have been studie d by bronc hoalve olar lavage (BAL) and bronchial biopsie s but the use of the se te chniques has be en limite d in ce rtain patie nts by the ir invas ive ne ss. In orde r to ove rc ome the diffic ultie s assoc iate d w ith bronchoalveolar lavage and the samp ling of bronchial biopsie s via the bronchoscope, analys is of induc ed sputum has re c ently bee n suggeste d for re peate d e valuation of airw ay inflammatio n in patie nts w ith asthma. Ex aminatio n of induc e d sputum allow s inve stigation the airw ay inflammatio n dire ctly w ithout important se condar y effe cts . Inflammator y marke rs can be studie d on cells and supe rnatants .
Inflammatio n plays a ke y role in the pathophysiology of as thma 1 and COPD. In bronchial biopsie s of patie nts w ith as thma, primarily e osinop hils, monocyte s/mac rop hages and T-lymphocyte s 1,2 are see n. In lobar bronchial biopsie s of subjec ts w ith chronic bronchitis , an inc re ase d numbe r of le ukoc yte s, both in the e pithe lium and in the lamina propria, c onsisting pre dominantly of macrophage s and ac tivate d T-cells, w as found. Eosinophils are the more promine nt c ells in asthma, and their activatio n is supposed to be invo lve d in tissue de struc tion. Epithelial bronchial c ells are now cons ide re d essential in modulating bronchial tissue s re modeling (subep ithe lial fibrosis , muscular hyp erplasia). How ever, T-lymphocyte s are still essential in asthma inflammation as the TH2 c ytokine s are characte ris tic of allergic pathw ays and partic ularly of as thma. More ove r, the major drugs used in as thma (ste roids) are pow erful immunos uppre ssors, re fle cting importanc e of the immunologic pathw ays.
Homeostasis of c ell numbe r is achie ved by balancing the prolife rative and anti-prolife rative state s of ce lls. Anti-prolife rative state s inc lude grow th arre st, diffe re ntiation, sene sc enc e (c ellular age ing), and apoptos is. Apoptosis, a dynamic proce ss invo lve d in the contro l of the 'tissue load' of immune effe ctor ce lls at inflame d site s, te nds to limit inflammatory tis sue injury and to promote re solution rath er than progression of inflammation. 3 The inflammatory process c ould be traduc ed by certain proto-oncogene s, w hich re gulate the p rogramme d ce ll de ath: apoptosis. Fas and the members of the Bcl-2 ge ne family have emerge d as ke y re gulators of the apoptotic proc ess. 4 In bronchial biopsie s, the number of apoptotic eosinophils and macrophages w as found to be low er in subje cts w ith asthma than those w ith COPD and inve rse ly corre late d w ith the clinic al severity of asthma, 5 re flecting longer survival of the se ce lls. As lymphocyte s are invo lve d in the initial events of re c ruitme nt and ac tivation of inflammatory cells, w e suppose d that the y have to dis appe ar to allow inflammation re solution. The aim of our study w as to inve stigate bronchial lymphoc yte s apoptos is in ac ute asthma ex ace rbation. The ce lls w ere re c ove re d on induc ed sputum. In this w ork, w e w ill discuss how the use of sputum, and the analys e s of apoptosis, promise to provide new insights into unde rs tanding inflammator y airw ay disease s.
Materials and methods

Patients
Induc ed sputum samples w ere colle cte d from 10 succ essive patie nts w ith asthma, and 12 patie nts w ith COPD (Table 1 ). All w ere inp atie nts, admitte d for an acute w hee zing ex ace rbation of dyspne a, usually by the eme rgenc y servic e s. The sample w as obtaine d the day afte r their admission. A pre cise his tory of the patie nt w as subse quently obtaine d, and afte r re cove ry func tional re spirato ry te sts and e ventually skin te sts w ere re alize d. The follow ing patie nts w e re ex clude d: conc omitant infe ctious pne umonia, tuberc ulosis, A. Ha m za o u i e t al.
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Sputum induction
Afte r the inhalation of salbutamol (2 3 200 m g), subjects w e re as ke d to inhale ste rile , p yroge n-fre e, hypertonic saline in inc re as ing c onc entrations for a duratio n of 10 min. The hypertonic saline w as ne bulized via an ultrasonic ne bulizer. Subjec ts w ere enc ourage d to cough throughout the proce dure . Most patie nts w e re able to ex pec torate an ade quate sample (7 ml and more ) w ithin the firs t 10 min.
Sputum processing
In orde r to re duc e salivar y c ontaminatio n, plugs 
Quantification of apoptosis
Lymphoc yte s w ere isolate d by Fic oll-Hypaque (Pharmacia, Uppsala, Sw e den) de ns ity gradie nt ce ntrifug atio n and w as he d tw ice w ith PBS at 4+°C, as w e have re ce ntly re porte d. 5 Ce ll p elle t ex pre sse d more than 80% CD3-p ositive ce lls as de te rmine d by anti-CD3 monoclonal antib ody (Bec ton Dickinson). The se T-c ells w ere double labe led w ith anti-CD3 and anti-CD25 monoclonal antib odie s in original (Be c ton Dickins on).
Apoptosis w as quantifie d on lymphoc yte s by staining nuc le i w ith propidium iodide (PI) and analys ing f luore sce nc e w ith a FACSc an (Bec ton Dickins on. Mountain Vie w, CA). Brie fly follow ing c ulture for 18 h, lymphoc yte s w ere c ollec te d afte r c entrifug atio n w ith RPMI 1640 at 150 g for 10 min. The pelle t w as w as he d tw ice in comple te medium (RPMI 1640 sup plemente d w ith 2 mM L-glutamine , 100 U/ml benzyl-p enic illin, 100 m g/ml stre ptomyc in and c ontaining 10% fe tal calf serum). The p elle t c olle c te d from induc e d sputum w as ge ntly suspe nde d in 0.5 ml of hypotonic fluochrome solution (0.1% sodium c itrate w ith 0.1% Trito n X-100) c ontaining 20 mg pe r m l PI for 2O min. RNAse A at a c onc entratio n of l0 mg/ml w as adde d and c ells w e re furthe r inc ubate d for 10 min at 4°C. The susp ension w as analy ze d by flow cytome try to de te rmine PI fluore sc enc e of indiv idual nuc le i. Apop totic nuc lei appe are d as a broad hypodiploṏd DNA p eak that w as e as ily dis criminate d from the narro w pe ak of nuc lei w ith normal (dip loid) DNA c onte nt. Stude nt's t-te st w as used for statis tic al analys is of data and p < 0.01 w as take n as signific ant.
Detection of Fas by immunochemistry
For measuring the ex pre ssion of the Fas -antige n, induc ed sputum cytospins w ere fix ed w ith ice -cold acetone for 10 min. Immunocytoche mical inve stigation of Fas w as performed using the stre p tav idin-biotin pre rox idas e-c omplex me thod. Ce ll pre paratio ns w ere pre -inc ubate d w ith hydroge n pe rox ide (0.3%, 15 min), unlabeled stre ptavidin (dilution 1:50, 15 min) and nonimmune normal sheep serum. Afte r e ach ste p slide s w ere w as hed thre e time s in PBS. The Fas -antib ody antib ody (Immunote ch, Franc e) w as used in a dilutio n as 
Results
Patients
According to clinic al his tory, func tional (spirometry, and re versibility w ith be ta2 agonists or ste roids) and skin te sts re sults, patie nts w ere classifie d as asthmatic patie nts or COPD. Chronic asthma se verity w as classifie d acc ording to GINA re comme ndatio ns. 6 Thre e patie nts w ere diffic ult to diagnose definite ly as as thma or COPD (A1, B11 and B12) but w e de cide d not to ex clude the m, the re sults obtaine d on their samples re flec ting a re al associatio n of the 2 diagnos is.
Differential cell counts
Diffe re ntial ce ll c ount in induc ed sputum w as re porte d in Table 2 
Quantification of apoptosis
Induc ed sputum lymphoc yte s from patie nts w ith asthma, patie nts w ith COPD and healthy controls, show ed spontane ous apoptosis (mean ± s.e.m.) afte r 18 h of culture of lymphoc yte s in the absenc e of mitogens ( Figure 1 ). The se lymphoc yte s w ere CD3-and CD25-positive . The perce ntage of apoptosis w as signific antly de cre ase d in patie nts w ith as thma (11.37% ± 5.31 %; p< 0.01) compare d w ith COPD patie nts (14.82% ± 4.46%), and he althy controls (26.09% ± 12.34%).
Patho genic c onc epts of allergic dis eases inc lude a ce ntral role for diffe re ntial cytokine produc tion, charac te rize d as Th0/Th2 p rofile . Then w e te ste d if ce rtain anti-c ytokine s antib odie s c ould block the apoptos is in patie nts w ith asthma, w ith COPD and in he althy contro ls. Induc ed sputum lymphocyte s w ere culture d in the pre senc e of vario us anti-cytokine antib odie s, anti-IL-2, anti-IL-4, anti-IL-10, anti-IL-13, and anti-TNF-a (Fig. 1) . Anti-IL-2 antib odie s inhibite d the apoptosis both in patie nts w ith asthma and patie nts w ith COPD by 45% and 7% re spec tive ly. Anti-IL-10 blocked apoptosis ex clusive ly in patie nts w ith asthma by 70%. Anti-TNFa antib ody inhibite d the apoptosis in both patie nts groups and healthy c ontrols , suggesting that TNF-a acte d as an induc e r of apoptosis .
Expression of Bcl-2 in induced sputum mononuclear cells
The analys is of Bcl-2, w hich is the apoptos is inhibiting prote in, w as e stimate d by Weste rn blotting. The re sults w ere highly re produc ible . The c onc ordanc e of the re pe ate d ex perime nts w as for Bcl-2 measure me nt of 87%.
The ex pre ssion of Bcl-2 w as found to be inc re ased in induc e d sputum lymphoc yte s for patie nts w ith asthma (32.7% ± 7.4%) compare d to healthy c ontrols (16.8% ± 6.2%) and p atie nts w ith COPD (13.9% ± 2.8%) (p < 0.01) (Fig. 2) low ex pre ssion of Fas c ould be de te c te d in patie nts w ith asthma, w hen compare d to COPD patie nts and to he althy contro ls (p < 0.01).
Discussion
Total ce ll count w as ele vate d in patie nts w ith asthma and patie nts w ith COPD, compare d to healthy controls. Sputum of patie nts w ith asthma and COPD ex pre sse d high pe rc entage s of eosinophils and lymphoc yte s. The lymphocyte s w e re in the majority CD3-positive (T-lymphoc yte s), and w ere activate d (CD25 + ). The le ukoc yte s c ount and phenotype of the lymphoc yte s show ed that sputum traduc e d an inflammatory state in patie nts w ith asthma and COPD. The re sults obtaine d from analyzing induc ed sputum in asthma and COPD patie nts re flec t the inflammatory status of the bronchi.
The perc entage of apoptosis w as signific antly decre as ed in patie nts w ith as thma compare d w ith COPD patie nts and he althy contro ls. Anti-IL-2 antibodie s inhibite d the apoptosis both in patie nts w ith asthma and patie nts w ith COPD. Anti-IL-10 blocke d apoptos is ex clusive ly in p atie nts w ith as thma. Anti-TNF-a antib ody inhibite d the apoptosis in both patie nts group s and healthy c ontrols , suggesting that TNF-a acte d as an induc e r of ap optos is .
The ex pre ssion of Bcl-2 w as found to be inc re ased in induc e d sputum lymphoc yte s from patie nts w ith asthma compare d to he althy c ontro ls and patie nts w ith COPD.
A signific antly low ex pre ssion of Fas c ould be dete cte d in p atie nts w ith asthma, w hen compare d to COPD patie nts and to healthy c ontro ls.
No c orre latio n w as found w ith asthma severity, or pre vious tre atme nt. This can be linke d to our protocol: all the sample s w ere colle cte d during an ac ute ex ace rbation re quiring an admission. We c an suppose that the severity of the acute proc ess w as similar w ithin the p atie nts and did not de pend on the se verity of the chronic dise ase . It w ould only depend on the pathology: asthma or COPD.
In an atte mpt to clarify if lymphocyte s survival is modifie d in asthma, w e inve stigate d induc ed sputum samples. The pe rc entage of apoptosis w as significantly dec re as ed in patie nts w ith asthma compare d w ith COPD p atie nts and healthy controls. The decre as ed apoptosis observe d in patie nts may be associate d w ith pers is te nc e of mononuc lear ce lls in the bronchial mucosa and lumen, during the ac ute ex ace rbations . The low ex p re ssion of apoptosis is more important in p atie nts w ith as thma, w hen compare d to COPD p atie nts . This finding sugge sts a partic ular involve me nt of lymphocyte s in ac ute asthma. Induc tion of apoptos is allow ing the re moval of the c ells may be esse ntial to re solve allergic inflammation, and the use of c ortic oste roids and theopylline in c ombination may be appropriate to induc e apoptos is in eosinophils and lymphocyte s. 8 Inte re stingly, Vignola et al. 5 found signific antly more apoptotic ce lls in the biopsy spec imens of patie nts w ith chronic bronchitis than in tissue s from asthmatic patie nts. The authors re p orte d also 5 that there is an imbalanc e betw e en the ex pre ssion of Bcl-2 and p53, w hich appe ars to be more important in asthma than in chronic bronchitis. The y conclude d that airw ay inflammatio n in as thma is as sociate d w ith an enhanc ed survival of diffe re nt c ell types caus ed by re duced ap optosis . Our finding s corroborate their finding s, but w e foc used on lymphoc yte s. The p erce ntage of inte ns ity of the proto-onc oge ne Bcl-2 w as inc re as ed more in patie nts w ith asthma w he n c ompare d to COPD and to the healthy contro l group. The Fas p roto-oncogene w hich is invo lve d in the induction of apoptosis w as signific antly dec re ased in patie nts w ith asthma, w he n c ompare d to COPD patie nts and to healthy c ontro ls. If the Fas is invo lve d in the induc tion of apoptosis at the same le ve l as p53, our re ports w ere in ac cordanc e w ith those of Vignola et al. 5 The Bcl-2 w as found to be inc re as ed in the tis sues from as thmatic subje cts compare d w ith those of the contro l subjec ts, and the ex pre ssion c orre late d w ith the severity of as thma. 5 Although Bcl-2 can be associate d w ith re side nt ce lls (mucous gland and smooth muscle), both prote in and me ssage w ere spe cific ally found in T-c ells of the inflammatory infiltrate in subjects w ith asthma and chronic bronchitis . 9 Upre gulate d Fas ligand may trigger the apoptotic death of Fas-be aring cells. This study re porte d the dow n ex pre ssion of Fas in lymphoc yte s in sputum of asthmatic patie nts. Functional Fas re c eptor ex pre ssion on eosinophils varie s among individuals w ith hypere osinophilia, and the survival c ytokine . 10, 11 We have found that certain spec ific anti-c ytokine s antibodie s blocked ap optosis , in partic ular anti-TNF-a and anti-IL10 in p atie nts w ith asthma. Anti-TNF-a inhibite d apoptos is in tw o patie nts groups and healthy controls. The blocking of apop tos is w ith anti-TNF-a antib ody indic ate d that TNF-a is involve d in induc ing ce ll death. 12, 13 This corre late s w ell w ith the finding s that se rum le ve ls of TNF-a inc re ase w ith the se verity of disease . 14 Inc ubation of lymphocyte s from asthmatic patie nts w ith anti-IL-10 antib ody dec re as ed apoptos is more signific antly than in patie nts w ith COPD or healthy controls. This show s that IL-10 had a sp ecific role in asthma. We have re c ently re porte d that IL-10 is able to inc re as e in vitro ex pre ssion of Bcl-2 in peripheral blood lymphoc yte s and in inflammator y lymphocyte s from broncho-ave olar lavage and c ere brospinal fluid. 7 It has bee n re p orte d that c ontinuou s c ulture of T-ce lls in the pre senc e of IL-10 w ill inhibit T-cell apoptosis, bec ause of, at leas t in part, the upre gulatio n of Bcl-2. 15 In patie nts w ith asthma, anti-IL-10 antib ody abolishe d apoptos is in asthma. This may have a partic ular signific anc e . Anti-IL-10 could have a diffe re nt effe ct on sputum T-lymphoc yte s or the action of anti-IL-10 w as diffe re nt, as has been obse rve d in vivo , or in vitro long-te rm culture (more than 48 hours ). IL-10, a product of T helpe r 2 lymphocyte s, has be en show n to be an important re gulator of peptide and alloantige ninduc ed T-c ell prolife ratio n and IL-2 produc tion. 16 Human IL-10 ex erts a dose-depe nde nt inhibitory e ffec t on human stimulate d lymphocyte s in vitro . 16 Inte rle ukin-2 is a major T-ce ll grow th fac tor, and anti-IL-2 antib ody inhibit apoptosis . 17 In the pre se nt re port anti-IL-2 antib ody inhibite d apoptosis more in asthma and COPD than in healthy c ontro ls. This finding c ould be ex plaine d by the fac t that T-lymphocyte s in sputum of patie nts playe d an inflammator y role and w ere probably produc ing high levels of inflammatory me diato rs. The anti-cytokine s data furthe r substantiate that IL-2 and IL-10 are critic al fac tors during inflammatory proce ss in the lung.
Apoptos is signals are furthe r modulate d by inhibitors or induc e rs of apoptosis inc luding Bcl-2, p53, Fas-ligand. Further unde rstanding of the inte rac tion of these mole cules in asthma and COPD may lead to more spe cific the rapie s for immunosuppre ssion tailore d to the gene tic or enviro nme ntally induc e d, activatio n-induc ed apoptosis defec t in p atie nts w ith asthma.
